###begin article-title 0
Cross-Talk between TLR4 and FcgammaReceptorIII (CD16) Pathways
###end article-title 0
###begin p 1
Conceived and designed the experiments: DR MAF JVS MSHL PAW. Performed the experiments: DR MAF DED BAN FSZ. Analyzed the data: DR MAF DED BAN FSZ JVS CMW GAW HPS MSHL PAW. Contributed reagents/materials/analysis tools: DR FSZ. Wrote the paper: DR PAW.
###end p 1
###begin p 2
###xml 306 314 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 319 326 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 345 353 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 630 638 622 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 877 884 865 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1075 1078 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1116 1119 1104 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1120 1124 <span type="species:ncbi:10090">mice</span>
Pathogen-pattern-recognition by Toll-like receptors (TLRs) and pathogen clearance after immune complex formation via engagement with Fc receptors (FcRs) represent central mechanisms that trigger the immune and inflammatory responses. In the present study, a linkage between TLR4 and FcgammaR was evaluated in vitro and in vivo. Most strikingly, in vitro activation of phagocytes by IgG immune complexes (IgGIC) resulted in an association of TLR4 with FcgammaRIII (CD16) based on co-immunoprecipitation analyses. Neutrophils and macrophages from TLR4 mutant (mut) mice were unresponsive to either lipopolysaccharide (LPS) or IgGIC in vitro, as determined by cytokine production. This phenomenon was accompanied by the inability to phosphorylate tyrosine residues within immunoreceptor tyrosine-based activation motifs (ITAMs) of the FcRgamma-subunit. To transfer these findings in vivo, two different models of acute lung injury (ALI) induced by intratracheal administration of either LPS or IgGIC were employed. As expected, LPS-induced ALI was abolished in TLR4 mut and TLR4-/- mice. Unexpectedly, TLR4 mut and TLR4-/- mice were also resistant to development of ALI following IgGIC deposition in the lungs. In conclusion, our findings suggest that TLR4 and FcgammaRIII pathways are structurally and functionally connected at the receptor level and that TLR4 is indispensable for FcgammaRIII signaling via FcRgamma-subunit activation.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 983 991 967 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The immune system is traditionally divided into innate and adaptive entities. Pattern-recognition receptors (PRRs) collectively recognize molecular structures of invading microorganisms, followed by initiation of immune responses. PRRs comprise the toll-like receptor (TLR) family, including TLR4, which is essential for responses to bacterial lipopolysaccharide (LPS). As part of the adaptive immune system, Fc receptors (FcRs) on immune cells recognize antigen-antibody complexes and link antibody-mediated immune responses to cellular effector functions. Here, we describe cross-talk between the pathogen-recognition-receptor toll-like receptor 4 (TLR4) and receptors for IgG immune complexes (IgGIC), Fcgamma receptors (FcgammaRs). We found that TLR4 is involved in FcgammaRIII (CD16) signaling and that heterodimerization of TLR4 and FcgammaRIII occurs in the presence of IgGIC but not LPS. Consequently, dysfunctional TLR4 signaling results in unresponsiveness of immune cells in vitro to both LPS and IgGIC, resulting in absence of acute lung injury after intratracheal administration of LPS or intrapulmonary immune complex deposition. In summary, we describe that TLR4 and FcgammaRIII pathways are structurally and functionally connected. These findings provide new insights of the interplay between innate and adaptive immunity, which closely interact with each other at the receptor level and post receptor signaling pathways.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 596 599 596 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Trinchieri1">[1]</xref>
###xml 772 775 772 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Akira1">[2]</xref>
###xml 860 863 860 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Medzhitov1">[3]</xref>
###xml 994 997 994 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Medzhitov1">[3]</xref>
###xml 998 1001 998 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Poltorak1">[4]</xref>
###xml 1132 1135 1132 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Jiang1">[5]</xref>
###xml 1136 1139 1136 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Yu1">[6]</xref>
###xml 1413 1416 1409 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-May1">[7]</xref>
The immune system is traditionally divided into innate and adaptive entities. Adaptive immunity is organized around T cells and B cells and requires a process of maturation and clonal selection of lymphocytes. In contrast, innate immunity can be immediately activated during the onset of infection in order to control replication of pathogenic microbes and bring about their clearance from tissues or blood. As an important aspect of innate immunity, pattern-recognition receptors (PRRs) collectively recognize lipid, carbohydrate, peptide, and nucleic-acid structures of invading microorganisms [1]. PRRs comprise the toll-like receptor family (TLR), which consists of at least 12 different evolutionarily conserved membrane proteins that trigger innate immune responses [2]. Initially identified in 1997, TLR4 represents the most thoroughly investigated TLR [3]. TLR4 is essential for responses to bacterial lipopolysaccharide (LPS), a well-known pathogen-associated molecular pattern (PAMP) [3],[4]. Besides LPS, various endogenous ligands, such as hyaluronan and high mobility group box 1 protein (HMGB1), appear to engage TLR4 [5],[6]. After binding of LPS to the TLR4/MD-2/CD14 receptor complex, activation of the intracellular signaling pathway is initiated, ultimately leading to NF-kappaB activation and its translocation to the nucleus, resulting in subsequent cytokine/chemokine production and release [7].
###end p 6
###begin p 7
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Gessner1">[8]</xref>
###xml 425 428 425 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Selvaraj1">[9]</xref>
###xml 668 671 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Gessner1">[8]</xref>
###xml 1080 1084 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Ravetch1">[10]</xref>
###xml 1085 1089 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Miettinen1">[11]</xref>
###xml 1090 1094 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Amigorena1">[12]</xref>
###xml 1095 1099 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Nimmerjahn1">[13]</xref>
As part of the adaptive immune system, antibodies of high affinity binding specifically recognize and neutralize intruding pathogens or their products. After antibody binding to antigen, the Fc domain of immunoglobulin (Ig) is recognized by Fc receptors (FcRs) which are predominantly expressed on immune and inflammatory cells and thereby link antibody-mediated (humoral) immune responses to cellular effector functions [8],[9]. Specific FcRs exist for all classes of immunoglobulins. Binding of IgGs to FcgammaRs on phagocytes triggers a wide variety of cellular functions including phagocytosis, release of inflammatory mediators, and clearance of immune complexes [8]. FcgammaRs specifically bind IgG and are divided into four subclasses. FcgammaRI (CD64), FcgammaRIII (CD16), and FcgammaRIV are activating receptors, while FcgammaRII (CD32) mediates inhibitory functions. The cellular response is determined by the balance between activating (ITAM, immunoreceptor tyrosine-based activation motif) and inhibitory (ITIM, immunoreceptor tyrosine-based inhibitory motif) signals [10],[11],[12],[13].
###end p 7
###begin p 8
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Schnare1">[14]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Fearon1">[15]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Kim1">[16]</xref>
###xml 378 382 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Nimmerjahn1">[13]</xref>
###xml 383 387 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Iwasaki1">[17]</xref>
###xml 634 641 622 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 716 720 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-AbdollahiRoodsaz1">[18]</xref>
###xml 721 725 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-vanLent1">[19]</xref>
###xml 726 730 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Banas1">[20]</xref>
###xml 852 860 836 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 865 872 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Despite extensive research in the past, the highly complex regulation of innate and adaptive immunity and their interactions are still poorly understood. It has been suggested that adaptive immune responses are controlled by innate immune recognition and vice versa [14],[15],[16]. In particular, TLRs and FcgammaRs are considered to be important regulators of immune responses [13],[17]. Recently, evidence has emerged that there is indirect interaction between TLR4 and FcgammaR pathways. TLR4 has been shown to up-regulate FcgammaR expression in experimental immune complex arthritis; inhibition of TLR4 resulted in attenuation of in vivo cytokine release in models of glomerulonephritis and rheumatoid arthritis [18],[19],[20]. In the present study, we addressed the question as to whether there is a direct link between TLR4 and FcgammaR pathways in vitro and in vivo.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Exclusion of LPS Contamination of Reagents
###end title 10
###begin p 11
###xml 149 152 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Jiang1">[5]</xref>
###xml 395 401 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 499 501 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 918 926 918 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1019 1026 1019 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1383 1391 1383 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1396 1403 1396 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 395 401 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
In the past, the investigation of TLR4 faced the problem of LPS contamination, which imposed considerable restrictions on the interpretation of data [5]. Therefore, the LPS concentration was determined in reagents used for lung injury induction by deposition of IgG immune complexes (IgGIC), such as DPBS, anti-BSA IgG and BSA, although none of these reagents had been prepared using bacterial (E.coli) systems. Using Limulus Amebocyte Lysate Kinetic-QCL assay, LPS levels were not detectable (<5x10-3 units/ml) in any of the reagents (data not shown), suggesting that in vitro stimulation by IgGIC is based upon a genuine agonist effect that is not due to LPS contamination. In addition to determination of LPS contamination (see above), DPBS, anti-BSA IgG and BSA were subjected to endotoxin removal by solid-phase polymyxin. Using the polymyxin-treated reagents, immune complexes were generated and then applied in in vitro experiments or the reagents were administered in mice for the formation of immune complexes in vivo. Furthermore, commercially available, preformed peroxidase/anti-peroxidase immune complexes (PAP IgGIC) were used at the same concentration in order to confirm the results using BSA IgGIC or polymyxin-treated BSA IgGIC. The results of both, polymyxin-treated BSA IgGIC and PAP IgGIC, are presented in the corresponding figures. In summary, using different in vitro and in vivo approaches, it is highly unlikely that any of the effects following IgGIC stimulation in the present study are based on LPS contamination of the reagents.
###end p 11
###begin title 12
Association between TLR4 and FcgammaRIII after IgG Immune Complex Activation
###end title 12
###begin p 13
###xml 173 181 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 378 389 370 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1A,B</xref>
###xml 721 732 701 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1A,B</xref>
###xml 891 895 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Santiago1">[21]</xref>
###xml 896 900 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Huizinga1">[22]</xref>
###xml 1115 1119 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Warmerdam1">[23]</xref>
###xml 1120 1124 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Gruel1">[24]</xref>
###xml 1141 1152 1105 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1A,B</xref>
###xml 1335 1346 1295 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1C,D</xref>
###xml 1443 1454 1403 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1C,D</xref>
###xml 1644 1647 1596 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1678 1686 1630 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1794 1805 1742 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1E,F</xref>
###xml 2220 2231 2154 2165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1G&#8211;J</xref>
###xml 2337 2348 2267 2278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1G,H</xref>
###xml 2411 2422 2341 2352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1I,J</xref>
###xml 2779 2788 2705 2714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1K</xref>
###xml 2891 2902 2817 2828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1A,B</xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 1648 1652 <span type="species:ncbi:10090">mice</span>
###xml 2608 2612 <span type="species:ncbi:10090">mice</span>
In order to assess whether crosstalk between TLR4 and FcgammaR might occur at the receptor level, neutrophils (PMNs) and macrophages from wild-type (Wt) mice were incubated in vitro with IgGIC, LPS, or the combination of the two. After incubation, cell lysates were immunoprecipitated (IP) with anti-TLR4 and then analyzed for FcgammaRII/III by immunoblotting (IB). As shown in Figure 1A,B, immunoprecipitated TLR4 was associated with FcgammaR after cell exposure to IgGIC. Inversely, LPS incubation did not result in an association of both receptors as indicated by the absence of bands for FcgammaR, whereas the combination of LPS+IgGIC seemed to enhance the signal for FcgammaR co-immunoprecipitated by anti-TLR4 IgG (Figure 1A,B). The band for FcgammaR under the conditions described above indicated a protein mass of 55 kDa, in accord with the reported molecular weight for FcgammaRIII [21],[22]. In contrast, there was no band at the 40 kDa position (data not shown), the molecular weight of FcgammaRII, which is also recognized by the anti-FcgammaR antibody (mAb, clone 2.4G2) used for Western blot analyses [23],[24]. In accord with Figure 1A,B, reverse direction immunoprecipitation using FcgammaRIII antibody followed TLR4 Western blots revealed bands at around 90 kDa, consistent with the reported molecular weight of TLR4 (Figure 1C,D). However, under these conditions bands also occurred after stimulation of phagocytes with LPS (Figure 1C,D), which may suggest that FcgammaRIII and TLR4 heterodimerize upon LPS stimulation, although to a lesser extent as compared to IgGIC treated cells. When PMNs and macrophages from FcgammaRIII-/- mice were exposed to the same in vitro conditions (IgGIC, LPS, LPS+IgGIC), the band for FcgammaRIII failed to appear, confirming its specificity (Figure 1E,F). In order to examine whether the interaction between TLR4 and FcgammaRIII was specific for these two receptors or whether there also might be multimerization with other TLRs or Fc receptors, lysates from Wt phagocytic cells under various conditions (see above) were subjected to immunoprecipitation with anti-TLR6 or anti-CD23 (anti-FcepsilonRII), followed by Western blots for FcgammaRIII or TLR4, respectively (Figure 1G-J). In both combinations, specific bands for either FcgammaRIII (after immunoprecipitation with anti-TLR6; Figure 1G,H) or TLR4 (immunoprecipitation of cell lysates with anti-TLR6; Figure 1I,J) failed to appear, whereas the strong bands in the lower panels (loading controls) demonstrate that immunoprecipitation of the samples worked properly. In addition, macrophages from Wt mice were incubated with polymyxin-treated BSA IgGIC and PAP IgGIC, followed by immunoprecipitation with anti-TLR4 and Western blotting with anti-FcgammaRIII. As shown in Figure 1K, receptor heterodimerization occurred under these conditions as well, confirming the results shown in Figure 1A,B.
###end p 13
###begin title 14
Association between TLR4 and FcRgammaIII.
###end title 14
###begin p 15
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 82 85 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 106 114 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 544 547 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Peritoneal PMNs and macrophages (3x106 cells/ml) from Wt mice and FcRgamma-subunit-/- mice were incubated in vitro for 30 min with either IgG immune complexes (IgGIC; 100 microg/ml), LPS (20 ng/ml), or the combination. (A,B) Western blot analysis (IB) for FcgammaRIII of Wt PMN or macrophage lysates co-immunoprecipitated (IP) with anti-TLR4. (C,D) Reverse direction immunoprecipitation using anti-FcgammaRII/III IgG followed by Western blot analysis for TLR4. (E,F) Western blot analysis for FcgammaRIII of PMNs or macrophages from FcgammaRIII-/- co-immunoprecipitated (IP) with anti-TLR4. (G,H) Samples were immunoprecipitated with anti-TLR6 IgG and probed for FcgammaRIII. (I,J) Immunoprecipitation with anti-CD23 followed by Western blots using anti-TLR4 IgG. (K) Western blots (IB) of cell lysates of Wt macrophages that were incubated for 30 min with BSA IgG immune complexes (IgGIC; 100 microg/ml), polymyxin-treated BSA IgG immune complexes (p.-t. BSA IC; 100 microg/ml) or peroxidase/anti-peroxidase IgGIC immune complexes (PAP IC, 100 microg/ml). IB for FcgammaRIII of Wt macrophage lysates co-immunoprecipitated (IP) with anti-TLR4. Corresponding loading controls are displayed in lower panels.
###end p 15
###begin p 16
In summary, these findings indicate that association of TLR4 and FcgammaRIII occurs following activation of phagocytes with IgGIC and/or LPS and that this receptor association is a specific phenomenon for FcgammaRIII and TLR4.
###end p 16
###begin title 17
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Attenuated In Vitro Cytokine Production by TLR4 Mutant PMNs and Macrophages Following IgGIC or LPS Exposure
###end title 17
###begin p 18
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 296 304 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2</xref>
###xml 488 499 480 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2A&#8211;D</xref>
###xml 594 605 586 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2E,F</xref>
###xml 737 746 729 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2E</xref>
###xml 1008 1019 992 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2E,F</xref>
###xml 1224 1235 1208 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2E,F</xref>
###xml 1297 1305 1281 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
Elicited peritoneal neutrophils (PMNs) and macrophages were obtained from Wt and TLR4 mut mice. The cells were incubated in vitro with IgGIC or LPS. Subsequently, supernatant fluids were collected and evaluated by ELISA for intereukin-6 (IL-6) and tumour necrosis factor alpha (TNFalpha) levels (Figure 2). PMNs from Wt mice showed significant release of IL-6 and TNFalpha after exposure to either IgGIC or LPS. In the case of TLR4 mut PMNs, cytokine responses to IgGIC or LPS were lost (Figure 2A-D). When peritoneal macrophages were employed in the same protocol, similar results were found (Figure 2E,F). There was a 4-fold increase in IL-6 after exposure of Wt macrophages to LPS, and a 3-fold increase in IL-6 after IgGIC exposure (Figure 2E). Likewise, there was a robust release of TNFalpha by Wt macrophages into supernatant fluids after stimulation with IgGIC or LPS. When TLR4 mut macrophages were used under the same conditions, IL-6 and TNFalpha responses to IgGIC or LPS were greatly abolished (Figure 2E,F). Similar results were found when macrophages were incubated with polymyxin-treated BSA IgGIC or PAP IgGIC indicating that the results are reproducible and not based on LPS contamination of the reagents (Figure 2E,F). Thus, the lack of a functional TLR4 is associated with the in vitro inability of PMNs and macrophages to respond to LPS or IgGIC.
###end p 18
###begin title 19
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro cytokine responses of elicited peritoneal PMNs and macrophages to LPS and IgGIC.
###end title 19
###begin p 20
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 1042 1047 <span type="species:ncbi:10090">mouse</span>
In vitro cytokine responses of elicited peritoneal PMNs (A-D) and macrophages (E,F). Cells (3x106 cells/ml) from either Wt or TLR4 mut mice were incubated for 4 hr with LPS (20 ng/ml) or IgGIC; 100 microg/ml), respectively. In addition, macrophages were incubated with polymyxin-treated BSA IgG immune complexes (p.-t. BSA IC, 100 microg/ml) or peroxidase/anti-peroxidase IgGIC immune complexes (PAP IC, 100 microg/ml). (A) IL-6 release from PMNs after LPS stimulation. (B) TNFalpha levels after incubation of PMNs with LPS. (C) Concentration of IL-6 in supernatants when PMNs were exposed to IgGIC. (D) Production of TNFalpha by PMNs and macrophages in the presence of IgGIC. Ctrl = control levels of non-stimulated cells. (E) Release of IL-6 by macrophages into supernatant fluids after stimulation with LPS, IgGIC, p.-t. BSA IC, or PAP IC. (F) TNFalpha production by macrophages exposed to LPS, IgGIC, p.-t. BSA IC, or PAP IC. The experiments were performed in triplicates for each condition (each bar) with n>/=3 donors of cells for each mouse strain, Wt or TLR4 mut. Differences between controls and stimulated cells were-if not otherwise noted-statistically significant (p<0.05).
###end p 20
###begin p 21
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Wang1">[25]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Zhang1">[26]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Takeda1">[27]</xref>
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000464.s001">Figure S1</xref>
###xml 400 416 400 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000464.s001">Figure S1A,C,E,G</xref>
###xml 432 448 428 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000464.s001">Figure S1B,D,F,H</xref>
###xml 473 481 469 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 609 621 605 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000464.s001">Figure S1A&#8211;D</xref>
###xml 640 652 636 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000464.s001">Figure S1E&#8211;H</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
In order to assess if the impaired response of TLR4 mut cells observed in vitro might be due to a general impairment of the inflammatory response, peritoneal PMNs and macrophages from Wt and TLR4 mut mice were exposed to opsonized zymosan particles as well as to Pam3Cys, which is a specific ligand for TLR2 [25],[26],[27] . As displayed in Figure S1, Wt cells showed a significant increase of IL-6 (Figure S1A,C,E,G) and TNFalpha (Figure S1B,D,F,H) release when incubated in vitro with Pam3Cys or opsonized zymosan particles. In contrast to the findings described above (incubation with LPS or IgGIC), PMNs (Figure S1A-D) and macrophages (Figure S1E-H) from TLR4 mut mice showed full responses for IL-6 and TNFalpha when incubated with opsonized zymosan particles or Pam3Cys. These data indicate that the ability to produce cytokines in response to non-TLR4 agonists is intact in TLR4 mut cells and that the impairment of the inflammatory response to LPS and IgGIC is specific for the non-functional TLR4 protein.
###end p 21
###begin p 22
###xml 163 166 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 375 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g003">Figure 3</xref>
###xml 404 407 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 423 426 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 582 585 558 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 601 604 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 666 669 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 718 721 678 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 802 805 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 942 945 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 979 990 927 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g003">Figure 3C,D</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
In another set of experiments, cells from FcgammaRIII-deficient mice were tested for responsiveness to LPS. Peritoneal PMNs and macrophages from Wt and FcgammaRIII-/- were incubated with LPS and opsonized zymosan (as a positive control) under the same conditions described above and supernatant fluids were analyzed for IL-6 and TNFalpha levels by ELISA. As shown in Figure 3, phagocytes from FcgammaRIII+/+ and FcgammaRIII-/- mice robustly produced cytokines when incubated with LPS, opsonized zymosan or IgGIC. There was no difference in cytokine secretion between the FcgammaRIII+/+ and FcgammaRIII-/- cells, except for LPS-induced TNFalpha release by FcgammaRIII-/- PMNs, which was lower as compared to FcgammaRIII+/+ PMNs, but significantly elevated above baseline levels. As expected, FcgammaRIII+/+ macrophages robustly released IL-6 and TNFalpha into supernatant fluids when stimulated with IgGIC, whereas macrophages from FcgammaRIII-/- mice were unresponsive to IgGIC (Figure 3C,D).
###end p 22
###begin title 23
Responsiveness of FcgammaRIII-deficient phagocytes to LPS.
###end title 23
###begin p 24
###xml 67 70 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Peritoneal PMNs (A,B) and macrophages (C,D) from Wt and FcgammaRIII-/- mice were incubated to LPS (100 ng/ml) or Zymosan (300 microg/ml), or IgG immune complexes (IgGIC; 100 microg/ml; macrophages only), and supernatant fluids were analyzed for IL-6 and TNFalpha levels. Ctrl = control levels of non-stimulated cells. For each condition, n>/=4. Differences between controls and stimulated cells were-if not otherwise noted-statistically significant (p<0.05).
###end p 24
###begin p 25
These results suggest that FcgammaRIII-deficient phagocytes can respond to LPS and that FcgammaRIII is not required for direct TLR4 signaling, while FcgammaRIII is essential for the mediation of IgGIC-induced responses.
###end p 25
###begin title 26
Phosphorylation of FcR gamma-Subunit Requires the Integrity of TLR4
###end title 26
###begin p 27
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Takeda1">[27]</xref>
###xml 268 271 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Gessner1">[8]</xref>
###xml 272 276 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Strzelecka1">[28]</xref>
###xml 367 371 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Orloff1">[29]</xref>
###xml 372 376 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Duchemin1">[30]</xref>
###xml 459 463 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Baumann1">[31]</xref>
###xml 623 631 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 655 664 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4A</xref>
###xml 682 691 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4B</xref>
###xml 1063 1074 1029 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4A,B</xref>
###xml 1110 1121 1076 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4C,D</xref>
###xml 1331 1342 1289 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4C,D</xref>
###xml 1550 1559 1508 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4E</xref>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
After binding of LPS, TLR4 engages intracellular signaling pathways via the adaptor molecules MyD88 and TRIF [27]. In the case of FcgammaR-immune-complex interaction, intracellular pathways are activated by tyrosine phosphorylation of the FcRgamma-subunit ITAM region [8],[28]. This subunit is known to be the common adaptor of FcgammaRI, FcgammaRIII and FcepsilonRI [29],[30], the first two being essential for development of IgGIC induced acute lung injury [31]. In order to evaluate the mechanism behind the impaired response of TLR4 mut cells to IgGIC, tyrosine phosphorylation of the FcRgamma-subunit was investigated in vitro. When peritoneal PMNs (Figure 4A) or macrophages (Figure 4B) from Wt mice were exposed to IgGIC, rapid tyrosine phosphorylation (PY) of the FcRgamma-subunit occurred over the first 30 min, as indicated by robust bands in the Western blots. In striking contrast, phosphorylation of the FcRgamma-subunit failed to occur when TLR4 mut cells were used. Here, the intensity of the bands was comparable to those in non-stimulated cells (Figure 4A,B). When LPS was used as a stimulus (Figure 4C,D), slight phosphorylation of the FcRgamma-subunit occurred in Wt cells (but not in TLR4 mut cells), indicating that TLR4 has little ability to activate the FcRgamma-subunit as an intracellular signaling event (Figure 4C,D). Furthermore, the above mentioned results were confirmed in macrophages by using polymyxin-treated BSA IgGIC for stimulation under the same conditions in order to exclude LPS contamination of the reagents (Figure 4E). Collectively, these data suggest that the integrity of TLR4 seems to be required for a proper function of FcgammaR activation via phosphorylation of the FcRgamma-subunit, further suggesting communication between the TLR4 and FcgammaR signaling pathways.
###end p 27
###begin title 28
###xml 107 115 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Western blot analysis for tyrosine-phosphorylated (PY) FcRgamma-subunit of PMN or macrophage lysates after in vitro incubation.
###end title 28
###begin p 29
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
(A,B) 3x106 cells/ml from either Wt or TLR4 mut mice were incubated for 5, 15, and 30 min with IgG immune complexes (IgGIC; 100 microg/ml). (C,D) The same protocol was used for stimulation with LPS (20 ng/ml). (E) Lysates from either Wt or TLR4 mut mice that were incubated with polymyxin-treated BSA immune complexes (100 microg/ml) under the same conditions as described above. Corresponding loading controls are displayed in the lower panels.
###end p 29
###begin title 30
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
Acute Lung Injury in Wt, TLR4 Mutant, and TLR4-/- Mice
###end title 30
###begin p 31
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 229 233 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Baumann1">[31]</xref>
###xml 234 238 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Chouchakova1">[32]</xref>
###xml 309 313 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Saito1">[33]</xref>
###xml 314 318 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Andonegui1">[34]</xref>
###xml 319 323 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Jeyaseelan1">[35]</xref>
###xml 341 350 337 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5A</xref>
###xml 634 643 630 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5B</xref>
###xml 814 823 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5B</xref>
###xml 830 833 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 977 988 973 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5A,B</xref>
###xml 1153 1162 1149 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5C</xref>
###xml 1214 1223 1206 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5D</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
Using the LPS and IgGIC models of ALI, Wt, TLR4 mut, TLR4+/+ and TLR4-/- mice were evaluated for responses following lung deposition of IgGIC or LPS. While FcgammaRs play a key role in the IgG immune complex (IgGIC) model of ALI [31],[32], TLR4 is critical for the development of lung injury in the LPS model [33],[34],[35]. As indicated in Figure 5A, LPS-induced lung injury, as defined by the permeability index (leak of plasma albumin into the extravascular lung compartment), showed a 4-fold increase in Wt mice (compared to controls, ctrl) and remained at the control level in LPS-challenged TLR4 mut mice. In the case of IgGIC (Figure 5B), the permeability index rose 5-fold above control (basal) levels in Wt mice. However, TLR4 mut mice unexpectedly showed no evidence of injury after deposition of IgGIC (Figure 5B). TLR4-/- mice behaved similar to TLR4 mut mice in terms of lung injury, with virtually no lung injury in response to deposition of either LPS or IgGIC (Figure 5A,B). When IL-6 levels were measured in bronchoalveolar lavage (BAL) fluids, LPS and IgGIC induced high levels of IL-6 in Wt mice and very low levels in TLR4 mut mice (Figure 5C). Similar patterns were found for TNFalpha levels (Figure 5D).
###end p 31
###begin title 32
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Parameters of acute lung injury in Wt and TLR4 mut mice.
###end title 32
###begin p 33
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 863 866 853 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 914 917 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
(A) Lung injury (as measured by leak of 125I-BSA into lung) in Wt, TLR4 mut, TLR4+/+, and TLR4-/- mice receiving LPS intratracheally. (B) Permeability indices in Wt, TLR4 mut, TLR4+/+, and TLR4-/- mice after intrapulmonary immune complex formation following administration of BSA (i.v.) and anti-BSA IgG (i.t.). (C) IL-6 levels in BAL fluids after IgG immune complex (IgGIC)- or LPS-induced lung injury using Wt and TLR4 mut mice. (D) TNFalpha in BAL fluids from the same mice described in frame (C). For each bar, n>/=5. (E) Lung injury induced by IgG immune complexes (IgGIC) in Wt and TLR4 mut mice after endotoxin removal by polymyxin. (F) Lung permeability after intratracheal (i.t.) administration of anti-BSA IgG and intravenous (i.v.) injection of BSA, PBS i.t., and BSA i.v. or anti-BSA i.t. and PBS i.v. (G) IgGIC-induced lung injury in FcRgamma-subunit-/- mice in comparison to Wt mice (FcRgamma-subunit+/+). For each bar, n>/=5.
###end p 33
###begin p 34
###xml 113 122 113 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5E</xref>
###xml 175 184 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5B</xref>
###xml 615 622 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 719 728 719 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5F</xref>
###xml 983 986 983 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 1196 1212 1196 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5B and 5E</xref>
###xml 1307 1314 1307 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1665 1669 1653 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Takai1">[36]</xref>
###xml 1712 1715 1696 1699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1735 1738 1715 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1853 1862 1833 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5G</xref>
###xml 2170 2177 2146 2153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2340 2347 2316 2323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2353 2361 2329 2337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1573 1577 <span type="species:ncbi:10090">mice</span>
###xml 1689 1693 <span type="species:ncbi:10090">mice</span>
###xml 1739 1743 <span type="species:ncbi:10090">mice</span>
Similarly, induction of ALI by intrapulmonary deposition of polymyxin-treated BSA IgGIC in Wt and TLR4 mut mice (Figure 5E) revealed no difference to the results displayed in Figure 5B; when polymyxin-treated reagents were administered for intrapulmonary IgGIC formation lung permeability rose 3.5 fold in Wt mice whereas mice TLR4 mut mice did not show a significant increase. Thus, these findings support the conclusion that lung injury induction by IgGICs is not linked to contamination of the reagents with endotoxin. In addition, reagents that were used for the formation of IgGIC were administered separately in vivo at the same concentration as they were used in combination for intrapulmonary IgGIC deposition (Figure 5F). When BSA was injected intravenously, followed by intratracheal PBS injection lung permeability was not different from control mice. Similarly, intratracheal injection of anti-BSA and subsequent intravenous DPBS injection (containing a trace amount of I125-labelled BSA) did not result in increased lung permeability. In striking contrast, the combination of anti-BSA (i.t.) and by BSA (i.v.) injection lead to the development of acute lung injury, as also shown in Figure 5B and 5E. These data indicate that the development of lung injury in the IgG model is dependent on the in vivo formation of immune complexes and may not be explained by putative LPS contamination of the reagents since their separate, independent administration failed to increase lung permeability. Finally, IgGIC lung injury was induced in FcR gamma-subunit-deficient mice, which do not express FcgammaRI and FcgammaRIII on the surface of PMNs and macrophages [36]. In contrast to Wt mice (FcR gamma-subunit+/+), FcR gamma-subunit-/- mice did not develop acute lung injury after intrapulmonary IgGIC deposition, as determined by lung permeability (Figure 5G). These findings suggest that the IgGIC-induced lung injury using anti-BSA and BSA is strictly dependent on the FcgammaR-mediated signalling, and not on LPS-induced activation of TLR4. However, the caveat remains that there is always a concern about LPS contamination in the context of sensitive assays and in vivo responses. In particular, the possibility that LPS was present at concentrations below the detection limit of the available assays, which would not result in any in vivo (and in vitro) responses alone, but would be responsible for putative synergistic effects and an augmentation of IgGIC-induced inflammatory responses cannot be entirely excluded.
###end p 34
###begin title 35
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
Expression of FcgammaRIII, FcRgamma-Subunit, and C5aR in Wt and TLR4 Mutant Mice
###end title 35
###begin p 36
###xml 225 229 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Baumann1">[31]</xref>
###xml 230 234 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Mulligan1">[37]</xref>
###xml 235 239 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Ward1">[38]</xref>
###xml 381 392 373 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g006">Figure 6A,F</xref>
###xml 591 602 579 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g006">Figure 6B,C</xref>
###xml 713 722 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g006">Figure 6D</xref>
###xml 741 750 721 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g006">Figure 6E</xref>
###xml 834 845 814 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g006">Figure 6A,B</xref>
###xml 882 887 <span type="species:ncbi:10090">mouse</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
It is well established that engagement of FcgammaRIII with IgGIC as well as activation of the complement system with generation of C5a and its interaction with C5aR play crucial roles in the pathogenesis of IgGIC-induced ALI [31],[37],[38]. Therefore, elicited peritoneal PMNs were evaluated by flow cytometry for surface expression of FcgammaRII/III and C5aR protein. As shown in Figure 6A,F, the levels of each receptor on the surface of PMNs were the same in Wt versus TLR4 mut cells. The original flow cytometry data of FcgammaRII/III expression on Wt and TLR4 mut PMNs are displayed in Figure 6B,C. In addition, the total content of FcgammaRIII and FcRgamma-subunit in cell lysates from Wt and TLR4 mut PMN (Figure 6D) and macrophages (Figure 6E) were analyzed by Western blotting. In accordance with the flow cytometry results (Figure 6A,B), unstimulated phagocytes from both mouse strains expressed the same levels of FcgammaRII/III and FcRgamma-subunit. The analysis for the house keeping protein GAPDH (lower bands) indicates equal loading of the cell lysates. Thus, the inability of TLR4 mut mice to respond to IgGIC or LPS is not associated with reduced surface content of FcgammaR protein on PMNs, consistent with the findings that there is cross-talk between FcgammaR and TLR4 signaling pathways such that downstream production of IL-6 and TNFalpha upon IgGIC stimulation requires participation of both pathways. Collectively, these data indicate that TLR4 is required for proper FcgammaRIII functions.
###end p 36
###begin title 37
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Expression levels of FcgammaRII/III, FcRgamma-subunit, and C5aR on phagocytes from Wt and TLR4 mut mice.
###end title 37
###begin p 38
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
(A) Summary of flow cytometry analyses of FcgammaRII/III expression on blood PMNs. (B,C) Original flow cytometry results for FcgammaRII/III expression on the surface of PMNs from Wt (B) or TLR4 mut (C) mice. (D,E) Analysis of the expression of FcgammaRIII (upper bands) and FcRgamma-subunit (middle bands) in cell lysates [(D), PMNs; (E), macrophages] from Wt or TLR4 mut mice by Western blotting. The lower bands represent the analysis for GAPDH as loading controls. (F) Surface expression of C5aR protein on PMNs from Wt or TLR4 mut mice as assessed by flow cytometry. MFI, mean fluorescence intensity. Studies were done in three separate and independent experiments, with each sample run in duplicates.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 412 415 412 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Trinchieri1">[1]</xref>
###xml 683 687 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Strzelecka1">[28]</xref>
###xml 688 692 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Duchemin1">[30]</xref>
###xml 693 697 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Durden1">[39]</xref>
###xml 698 702 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Pfefferkorn1">[40]</xref>
###xml 846 850 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-GraziaCappiello1">[41]</xref>
###xml 953 957 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-GraziaCappiello1">[41]</xref>
###xml 1032 1036 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Schnare1">[14]</xref>
###xml 1136 1140 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Fearon1">[15]</xref>
###xml 373 378 <span type="species:ncbi:9606">human</span>
The mechanisms by which the recognition of pathogens leads to host responses are inadequately understood. The modulation of immune responses is inter alia mediated by cell surface receptors that are associated with signaling molecules that contain ITAMs (immunoreceptor tyrosine-based activation motifs), TREMs (triggering receptors expressed on myeloid cells) and OSCARs (human osteoclast-associated receptors) [1]. Intracellular signaling after TLR4 activation is mediated through the adaptor proteins, MyD88 and TRIF, whereas FcgammaRI and FcgammaRIII both contain the FcRgamma-subunit, which is phosphorylated at tyrosine residues by Src and Syk kinases upon FcgammaR activation [28],[30],[39],[40]. Interestingly, ligation of FcRgamma-subunit containing FcRs results in inhibition of IL-12 production by monocytes in response to TLR ligands [41]. The specificity of IL-12 downregulation appears to be based on inhibition at the transcription level [41]. Moreover, TLRs are considered to control activation of acquired immunity [14], supporting the hypothesis for an instructive role of innate immunity in adaptive immune responses [15].
###end p 40
###begin p 41
###xml 136 144 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 146 154 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g001">Figure 1</xref>
###xml 389 393 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Strzelecka1">[28]</xref>
###xml 394 398 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Duchemin1">[30]</xref>
###xml 399 403 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Pfefferkorn1">[40]</xref>
###xml 494 498 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Akira2">[42]</xref>
###xml 611 615 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Pfeiffer1">[43]</xref>
###xml 775 779 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Holifield1">[44]</xref>
###xml 934 938 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Medvedev1">[45]</xref>
###xml 1139 1147 1119 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4</xref>
###xml 595 600 <span type="species:ncbi:9606">human</span>
In the present study, we describe that TLR4 and FcgammaRIII associate, possibly by heterodimerization, following stimulation with IgGIC in vitro (Figure 1). Binding of IgGICs to the extracellular domain of FcgammaRs causes clustering of these receptors, followed by phosphorylation of tyrosine residues within the ITAM region, and subsequent activation of intracellular signaling cascades [28],[30],[40]. TLR signaling is initiated by dimerization of TLRs, which can form homo- or heterodimers [42]. Previously, it has been suggested that TLR4 co-associates with FcgammaRIII after activation of human monocytes [43]. Based on our findings, it is possible that TLR4 and FcgammaRIII multimerize into clusters following stimulation by LPS or IgGIC, a mechanism known as capping [44], which is required for engagement of intracellular signaling pathways. TLR4 may represent the central component for such signaling or "docking platforms" [45] and interconnect intracellular signaling pathways via association to adaptor proteins. As demonstrated in the present study, dysfunction of TLR4 results in impaired signaling in FcgammaRIII pathways (Figure 4).
###end p 41
###begin p 42
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Medvedev1">[45]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Medvedev1">[45]</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
The mutation that is responsible for the endotoxin tolerance of C3H/HeJ mice has recently been demonstrated to cause suppressed tyrosine phosphorylation by Src tyrosine kinases (Lyn) in the toll-IL-1 resistance (TIR) domain of TLR4, resulting in signaling-incompetence [45]. Altered or suppressed TLR4 tyrosine phosphorylation correlated with impaired MyD88 association and suppressed IRAK-1 activation [45]. In addition, our data suggest that this mutation in the TLR gene not only hinders phosphorylation of its own TIR domain but also blocks the tyrosine phosphorylation of the ITAM-containing FcRgamma-subunit, the consequence of which ultimately leads to impaired signaling after engagement of FcgammaRIII.
###end p 42
###begin p 43
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5</xref>
###xml 316 319 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Poltorak1">[4]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Saito1">[33]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Andonegui1">[34]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Jeyaseelan1">[35]</xref>
###xml 411 414 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 518 526 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5</xref>
###xml 668 672 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Baumann1">[31]</xref>
###xml 673 677 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Chouchakova1">[32]</xref>
###xml 783 787 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Baumann1">[31]</xref>
###xml 938 942 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Kohl1">[46]</xref>
###xml 1057 1064 1037 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1172 1180 1148 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g005">Figure 5</xref>
###xml 1209 1217 1185 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1380 1388 1352 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g002">Figure 2</xref>
###xml 1541 1549 1509 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g004">Figure 4</xref>
###xml 1693 1701 1661 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g003">Figure 3</xref>
###xml 1980 1988 1948 1956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2081 2089 2045 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000464-g003">Figure 3</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1374 1378 <span type="species:ncbi:10090">mice</span>
###xml 2047 2051 <span type="species:ncbi:10090">mice</span>
In the LPS model of acute lung injury, TLR4 mut or TLR4-/- mice were, as expected, highly protected from the development of tissue damage in the LPS-induced model of acute lung injury (Figure 5). It is well established that mice with mutation in the TLR4 gene or genetic deficiency of TLR4 are non-responsive to LPS [4], including LPS-mediated lung injury [33],[34],[35]. In the present study, TLR4 mut and TLR4-/- mouse strains unexpectedly also showed greatly attenuated susceptibility to IgGIC-induced lung injury (Figure 5). For this model, it is known that, besides complement activation, FcgammaRs are critical for initiation and development of IgGIC alveolitis [31],[32], particularly through engagement and activation of ITAM-containing FcgammaRs (FcgammaRI and FcgammaRIII) [31]. In accordance, mice with targeted disruption of the FcRgamma-subunit showed an impaired inflammatory response in the reverse passive Arthus reaction [46]. In our study, TLR4 mut mice not only were resistant to lung injury, but also failed to locally release cytokines in vivo after intrapulmonary IgGIC deposition, as indicated by baseline levels of IL-6 and TNFalpha in BAL fluids (Figure 5). In companion experiments, in vitro exposure of TLR4 mut phagocytes to IgGIC resulted in complete suppression of proinflammatory cytokines (TNFalpha, IL-6) in comparison to phagocytes from Wt mice (Figure 2). Furthermore, TLR4 mut cells showed impaired tyrosine phosphorylation of the FcRgamma-subunit when exposed to IgGIC, in striking contrast to Wt cells (Figure 4). The fact that TLR4 mut PMNs and macrophages responded with cytokine release when incubated with opsonized zymosan particles or with Pam3Cys (Figure 3) indicates that 1.) the mutation in the TLR4 gene does not lead to a global impairment of the cellular inflammatory/immune response and 2.) the intracellular signaling pathways are intact since other TLRs (such as TLR2 and TLR6), which share common pathways, could be activated in vitro. On the other hand, phagocytes from FcgammaRIII-deficient mice are fully responsive to LPS (Figure 3), suggesting that TLR4 signaling does not depend on the functional integrity of FcgammaRIII, whereas TLR4 is required for FcgammaRIII signaling.
###end p 43
###begin p 44
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Takaoka1">[47]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Horng1">[48]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Hawlisch1">[49]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Rittirsch1">[50]</xref>
Especially in the field of immunology, there is an increasing number of reports describing effects of receptor interactions. Examples include a previous study suggesting cross-talk between IFN-gamma and IFN-alpha receptors with signaling pathways [47]. In brief, signalling by IFN-gamma was shown to depend on the IFN-alpha/beta receptor components. A more recent publication describes that signalling triggered by NKG2D and DAP10 is coupled to the interleukin 15 receptor signalling pathway, suggesting that coupling of activating receptors to other receptor systems may regulate cell type-specific signaling events [48]. In the case of innate immunity, it has been proposed several times that there is a link between TLR4 and the complement system, especially to the C5a signalling pathway, which can negatively regulate TLR4-induced responses [49],[50]. Under physiological conditions, receptor interactions and cross-talk between signalling pathways might represent important regulatory mechanisms of the immune system to provide distinct but fine-tuned responses. In the case of TLR4 and FcgammaRIII, cross-talk may provide an optimal and rapid response against invading microorganisms by mediating an interplay between adaptive and innate immunity. However, in certain conditions, such as systemic inflammation (sepsis) or autoimmune diseases that are characterized by a loss of inhibitory action or uncontrolled activation of signalling pathways, a loss of control over otherwise carefully orchestrated receptor interactions can become instruments of harm.
###end p 44
###begin p 45
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 123 125 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii</italic>
###xml 318 321 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iii</italic>
Taken together, the present findings strongly suggest that (i) there is a direct link between TLR4 and FcgammaR pathways, (ii) phosphorylation of tyrosine residues in the ITAM-containing FcRgamma-subunit requires the presence and integrity of TLR4 during cellular activation after binding of IgGICs to FcgammaRs, and (iii) presence of IgGICs results in an association between TLR4 and FcgammaRIII (CD16) on phagocytic cells. These data imply that innate and adaptive immunity are closely connected at the receptor level and post receptor signaling pathways, which might have ramifications for a variety of inflammatory conditions, such as IgGIC-mediated autoimmune diseases (rheumatoid arthritis or glomerulonephritis), ischemia/perfusion injury, trauma or systemic inflammation (sepsis), etc.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47
Animals
###end title 47
###begin p 48
###xml 154 157 154 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Poltorak1">[4]</xref>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 315 318 315 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Poltorak1">[4]</xref>
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 395 398 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 420 406 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Sjv</sup>
###xml 409 420 401 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fcgr3<sup>tm1Sjv</sup></italic>
###xml 470 473 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 490 496 474 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Rav</sup>
###xml 484 496 468 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fcer1g<sup>tm1Rav</sup></italic>
###xml 545 549 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Hazenbos1">[51]</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
Adult male (22-25 g) specific pathogen-free C3H/OuJ (Wt) and C3H/HeJ (TLR4 mut) mice with a missense mutation in the TLR4-gene were used in these studies [4]. In addition, lung injury was employed in mice lacking the genes for TLR4 (TLR4-/-; C57BL/10ScCr) and the corresponding wild-type mice (TLR4+/+; C57BL/ScSn) [4]. In some in vitro experiments, cells from FcgammaRIII-deficient (FcgammaRIII-/-; B6.129P2-Fcgr3tm1Sjv/J), FcR gamma-subunit-deficient (FcRgamma-subunit-/-; B6.129P2-Fcer1gtm1RavN12) and appropriate Wt mice (C57BL/6) were used [51].
###end p 48
###begin title 49
Ethics Statement
###end title 49
###begin p 50
All studies were performed in accordance with the University of Michigan Committee on Use and Care of Animals.
###end p 50
###begin title 51
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
In Vitro Incubation of Peritoneal PMNs and Macrophages
###end title 51
###begin p 52
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
Mouse peritoneal leukocytes were harvested 5 h (PMNs) or 5 days (macrophages) after intraperitoneal injection of thioglycolate into untreated Wt and TLR4 mut mice by peritoneal lavage with PBS. 3x106 cells / sample were incubated in HBSS for up to 4 h at 37degreesC in the presence of LPS (20 ng/ml; serotype O111:B4; Sigma, St. Louis, MO), BSA IgG immune complexes (IgGIC, 100 microg/ml; MP Biomedicals), polymyxin-treated BSA IgG immune complexes (p.-t. BSA IC, 100 microg/ml), peroxidase/anti-peroxidase IgG immune complexes (PAP IC, 100 microg/ml; MP Biomedicals), opsonized zymosan particles (300 microg/ml; Sigma) or Pam3Cys (1 microg/ml; InvivoGen). After incubation, supernatant fluids were collected for assessment of cytokines by ELISA and pellets were lysed with RIPA buffer (Upstate) for immunoprecipitation analyses.
###end p 52
###begin title 53
Immunoprecipitation and Western Blotting
###end title 53
###begin p 54
###xml 132 136 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Czermak1">[52]</xref>
After incubation of peritoneal PMNs or macrophages with either IgG immune complexes (100 microg/ml; prepared as described elsewhere [52] or LPS (20 ng/ml) for 5 to 30 min, supernatant fluids were removed and pellets were lysed with 1X RIPA buffer containing Vanedate and protease inhibitors (Roche Diagnostics). Protein concentrations were determined in cell lysates using BCA protein assay (Pierce). Equal protein amounts of supernatants were then incubated overnight with preblocked protein A and G beads (Santa Cruz) in the presence of anti-FcRgamma-subunit IgG (Upstate) or anti-TLR4 IgG(Santa Cruz), respectively. Reverse direction immunoprecipitation included anti-FcgammaRIII IgG (Santa Cruz).
###end p 54
###begin p 55
###xml 301 307 <span type="species:ncbi:9913">bovine</span>
###xml 738 744 <span type="species:ncbi:9793">donkey</span>
###xml 750 754 <span type="species:ncbi:9925">goat</span>
###xml 810 814 <span type="species:ncbi:9925">goat</span>
###xml 820 823 <span type="species:ncbi:10116">rat</span>
###xml 864 870 <span type="species:ncbi:9793">donkey</span>
###xml 876 882 <span type="species:ncbi:9986">rabbit</span>
###xml 927 932 <span type="species:ncbi:9940">sheep</span>
###xml 938 943 <span type="species:ncbi:10090">mouse</span>
After centrifugation, pellets were resuspended in Laemmli sample buffer (Biorad) followed by boiling of the samples. After a final spin step, supernatant fluids were electrophoretically separated under reducing conditions in SDS-PAGE and transferred onto PVDF membrane. The membrane was blocked in 5% bovine milk in TBST and then probed for TLR4 or FcgammaRIII using polyclonal anti-TLR4 IgG (1 microg/ml, Santa Cruz) or monoclonal anti-FcgammaRII/III IgG (1 microg/ml; clone 2.4G2; BD Pharmingen). Alternatively, membranes containing the samples co-immunoprecipitated with anti-FcRgamma-subunit IgG were incubated with anti-phospho-tyrosine monoclonal antibody (1 microg/ml; clone 4G10, Upstate). As secondary antibodies, HRP-conjugated donkey anti-goat IgG (1:80,000; Jackson Immunoresearch), HRP-conjugated goat anti-rat IgG (1:10,000; Amersham) HRP-conjugated donkey anti-rabbit IgG (1:10,000; Amersham) and HRP-conjugated sheep anti-mouse IgG (1:20,000; Amersham) were added and the blot was developed using ECL-procedure (Amersham).
###end p 55
###begin title 56
###xml 10 15 <span type="species:ncbi:10090">Mouse</span>
ELISA for Mouse IL-6, TNFalpha
###end title 56
###begin p 57
###xml 80 88 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
For measurement of IL-6 and TNFalpha in BAL fluids and supernatant fluids after in vitro incubation of mouse PMNs and macrophages, commercially available ELISA-kits ("Duo set", R&D Systems) were used according to the manufacturer's protocol.
###end p 57
###begin title 58
Immune Complex Lung Injury
###end title 58
###begin p 59
###xml 344 347 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 390 393 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 854 857 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 85 91 <span type="species:ncbi:9986">rabbit</span>
###xml 184 189 <span type="species:ncbi:10090">mouse</span>
###xml 358 364 <span type="species:ncbi:9913">bovine</span>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
To induce IgGIC lung injury, tracheae of mice were surgically exposed and 125 microg rabbit anti-BSA IgG (MP Biomedicals) was administered using a 30 gauge needle (volume of 42 microl/mouse) followed by intravenous injection of BSA (500 microg; Sigma). For determination of the permeability index as a quantitative marker for vascular leakage, 125I-labelled bovine serum albumin (1 microCi 125I-BSA/mouse) was injected intravenously. After the development of acute lung injury, the pulmonary vasculature was flushed with 2.0 ml PBS. The amount of lung radioactivity was then measured as a ratio of radioactivity present in 100 microl blood recovered from the inferior vena cava at the time of animal euthanasia and that in lung. For bronchoalveolar lavage retrieval, lung injury was performed as described above, but without the intravenous injection of 125I-BSA. The airways were flushed with 0.8 ml ice cold PBS using a blunt 20 gauge needle and BAL fluids were recovered for further studies.
###end p 59
###begin title 60
LPS Lung Injury
###end title 60
###begin p 61
###xml 19 25 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 163 166 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 19 25 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
50 microg LPS from E.coli (serotype O111:B4; Sigma) were given intratracheally (volume of 42 microl/mouse). When lung permeability was measured, a trace amount of 125I-BSA was injected intravenously, as described above. The permeability index was determined and BAL fluids were collected as described for the IgGIC model.
###end p 61
###begin title 62
Detection of Possible LPS Contamination
###end title 62
###begin p 63
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000464-Niederbichler1">[53]</xref>
###xml 563 571 563 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Reagents other than LPS, such as DPBS, BSA, anti-BSA IgG that were used for the in vivo and in vitro experiments were tested for LPS-contamination. For quantification of LPS content, samples were conducted in Limulus Amebocyte Lysate Kinetic-QCL assay (Cambrex) according to the manufacturer's protocol and as described elsewhere [53]. In addition, reagents used for immune complex formation (DPBS, BSA, anti-BSA IgG) were subjected to endotoxin removal (Pierce) prior to induction of lung injury or preparation of immune complexes used stimulation of phagocytes in vitro.
###end p 63
###begin title 64
Analysis of FcgammaR and C5aR on PMNs
###end title 64
###begin p 65
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 142 148 <span type="species:ncbi:9986">Rabbit</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 247 253 <span type="species:ncbi:9986">rabbit</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 625 631 <span type="species:ncbi:9986">rabbit</span>
Flow cytometric analysis was conducted after whole blood collection of untreated wild-type and TLR4 mut mice in a citrate-containing syringe. Rabbit anti-mouse C5aR serum (1:10 dilution; Lampire) was incubated with mouse whole blood. Non-specific rabbit serum (Jackson Immunoresearch) was added to control samples in equal amounts. For detection of FcgammaR on PMNs, mouse whole blood was either incubated with 1 microg monoclonal anti-FcgammaRII/III IgG (clone 2.4G2; BD Pharmingen) or with the appropriate isotype IgG control (Jackson Immunoresearch). After washing, cells were suspended in Phycoerythrin (PE)-labeled anti-rabbit IgG (Invitrogen) diluted 1:200 in staining buffer and incubated at room temperature for 45 min. Erythrocytes were lysed by addition of 1x FACS lysing solution (BD Pharmingen) for 10 min. After washing, the leukocytes were resuspended in a 1%-paraformaldehyde fixing solution and analyzed on a flow cytometer (BD Pharmingen).
###end p 65
###begin title 66
Statistical Analysis
###end title 66
###begin p 67
###xml 271 272 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All values were expressed as mean+/-SEM. Data sets were analyzed by one-way analysis of variance (ANOVA); differences in mean values among experimental groups were then compared using Tukey multiple comparison test. Results were considered statistically significant when P<0.05.
###end p 67
###begin title 68
Supporting Information
###end title 68
###begin p 69
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
Cytokine response of PMNs and macrophages to Zymosan and Pam3Cys. In vitro cytokine responses to non-TLR4 agonists of elicited peritoneal phagocytes from Wt or TLR4 mut mice. PMNs (A-D) and macrophages (E-H) (3x106 cells/ml) were incubated (for 4 hr) with serum-opsonized zymosan particles (300 microg/ml) or Pam3Cys (1 microg/ml). Ctrl = control levels of non-stimulated cells. For each condition n>/=3. Differences between controls and stimulated cells were found to be statistically significant (p<0.05).
###end p 69
###begin p 70
(0.50 MB EPS)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
We thank Beverly Schumann and Sue Scott for excellent secretarial assistance in preparation of the manuscript.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Cooperation of Toll-like receptor signals in innate immune defence.
###end article-title 74
###begin article-title 75
Pathogen recognition and innate immunity.
###end article-title 75
###begin article-title 76
Innate immunity.
###end article-title 76
###begin article-title 77
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
###end article-title 77
###begin article-title 78
The role of Toll-like receptors in non-infectious lung injury.
###end article-title 78
###begin article-title 79
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
###end article-title 79
###begin article-title 80
Signal transduction through NF-kappa B.
###end article-title 80
###begin article-title 81
The IgG Fc receptor family.
###end article-title 81
###begin article-title 82
###xml 25 30 <span type="species:ncbi:9606">human</span>
Functional regulation of human neutrophil Fc gamma receptors.
###end article-title 82
###begin article-title 83
###xml 51 57 <span type="species:ncbi:10090">murine</span>
Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors.
###end article-title 83
###begin article-title 84
Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity.
###end article-title 84
###begin article-title 85
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes.
###end article-title 85
###begin article-title 86
Fcgamma receptors as regulators of immune responses.
###end article-title 86
###begin article-title 87
Toll-like receptors control activation of adaptive immune responses.
###end article-title 87
###begin article-title 88
The instructive role of innate immunity in the acquired immune response.
###end article-title 88
###begin article-title 89
Adaptive immune cells temper initial innate responses.
###end article-title 89
###begin article-title 90
Toll-like receptor control of the adaptive immune responses.
###end article-title 90
###begin article-title 91
Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.
###end article-title 91
###begin article-title 92
Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10.
###end article-title 92
###begin article-title 93
TLR4 links podocytes with the innate immune system to mediate glomerular injury.
###end article-title 93
###begin article-title 94
###xml 41 44 <span type="species:ncbi:10116">rat</span>
A specific Fc gamma receptor on cultured rat mesangial cells.
###end article-title 94
###begin article-title 95
The PI-linked receptor FcRIII is released on stimulation of neutrophils.
###end article-title 95
###begin article-title 96
###xml 38 43 <span type="species:ncbi:9606">human</span>
Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).
###end article-title 96
###begin article-title 97
###xml 36 41 <span type="species:ncbi:9606">human</span>
Purification of soluble recombinant human FcgammaRII (CD32).
###end article-title 97
###begin article-title 98
Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation.
###end article-title 98
###begin article-title 99
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.
###end article-title 99
###begin article-title 100
Toll-like receptors.
###end article-title 100
###begin article-title 101
Tyrosine phosphorylation and Fcgamma receptor-mediated phagocytosis.
###end article-title 101
###begin article-title 102
Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors.
###end article-title 102
###begin article-title 103
Clustering of the high affinity Fc receptor for immunoglobulin G (Fc gamma RI) results in phosphorylation of its associated gamma-chain.
###end article-title 103
###begin article-title 104
A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction.
###end article-title 104
###begin article-title 105
Fc gamma RIII-mediated production of TNF-alpha induces immune complex alveolitis independently of CXC chemokine generation.
###end article-title 105
###begin article-title 106
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse.
###end article-title 106
###begin article-title 107
Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs.
###end article-title 107
###begin article-title 108
Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury.
###end article-title 108
###begin article-title 109
FcR gamma chain deletion results in pleiotrophic effector cell defects.
###end article-title 109
###begin article-title 110
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Requirement and role of C5a in acute lung inflammatory injury in rats.
###end article-title 110
###begin article-title 111
Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury.
###end article-title 111
###begin article-title 112
Serine/threonine phosphorylation of the gamma-subunit after activation of the high-affinity Fc receptor for immunoglobulin G.
###end article-title 112
###begin article-title 113
Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2.
###end article-title 113
###begin article-title 114
Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation.
###end article-title 114
###begin article-title 115
Toll-like receptor signalling.
###end article-title 115
###begin article-title 116
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts.
###end article-title 116
###begin article-title 117
Comparative behavior of membrane protein-antibody complexes on motile fibroblasts: implications for a mechanism of capping.
###end article-title 117
###begin article-title 118
Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
###end article-title 118
###begin article-title 119
On the role of complement and Fc gamma-receptors in the Arthus reaction.
###end article-title 119
###begin article-title 120
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.
###end article-title 120
###begin article-title 121
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
###end article-title 121
###begin article-title 122
C5a negatively regulates toll-like receptor 4-induced immune responses.
###end article-title 122
###begin article-title 123
Functional roles for C5a receptors in sepsis.
###end article-title 123
###begin article-title 124
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.
###end article-title 124
###begin article-title 125
Mechanisms of enhanced lung injury during sepsis.
###end article-title 125
###begin article-title 126
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
###end article-title 126
###begin p 127
The authors have declared that no competing interests exist.
###end p 127
###begin p 128
This work was supported by National Institutes of Health grants GM-29507, GM-61656 () and HL-31963 () to PAW, and German Research Foundation grant HU 823/2-2 () to MSH-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 128

